kabi-story-1

Fresenius Kabi USA receives award for commitment to combating drug shortages

Fresenius Kabi USA received the Drug Shortage Guardian Award 2024 from the Angels for Change in May 2024. The mission of this organization is to look after patients during drug shortages. The award saluted the exceptional teamwork and the patient-centric focus, which enabled Fresenius Kabi USA to counter the critical chemotherapy shortage in 2023. The production of the required drugs in order to steward emergency supply to thousands of customers was rapidly increased to ensure access to therapies for the patients in need of treatment.

The initiative also presented individual awards to two Fresenius employees, recognizing the outstanding work and leadership qualities of Karen Twardzik, Vice President (Customer Service Operations), and Danielle Gross, Manager (Customer Service). These two employees made key contributions to ensuring prompt supply of lifesaving medicines to customers and patients across the country.

More about the initiative: www.angelsforchange.org

More on this in the chapter Access and Affordability.